← Back to Patent Explorer
US4438272A Expired / Lapsed US ⏱️ 0.0 years remaining

Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones

Assignee: Alcon Research LLC
•
Filing: 1982-04-15
•
Granted: 1984-03-20
•
Expires: 2002-04-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Tetracyclic spiro-hydantoin derivatives useful in the treatment of complications arising from diabetes mellitus.

Inventors

  • 👤 Billie M. York, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 18:22
CPC Classifications
C; C07; C07D; C07D235/00; C07D235/02

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 25 words
A spiro-(fluoren-9,4'-imidazolidine)-2', 5'-dione or pharmaceutically acceptable salt thereof having the formula ##STR10## Where x=hydrogen, fluoro, methylthio, methylsulfinyl, and methylsulfonyl, and y=fluoro, methylthio, melthylsulfinyl and methylsulfonyl.
Claim 2
Dependent Claim 25 words
A spiro-(fluoren-9,4'-imidazolidine)-2', 5'-dione or pharmaceutically acceptable salt thereof having the formula ##STR10## Where x=hydrogen, fluoro, methylthio, methylsulfinyl, and methylsulfonyl, and y=fluoro, methylthio, melthylsulfinyl and methylsulfonyl.
Claim 3
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR11##
Claim 4
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR12##
Claim 5
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR13##
Claim 6
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR14##
Claim 7
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR15##
Claim 8
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR16##
Claim 9
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR17##
Claim 10
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR18##
Claim 11
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR19##
Claim 12
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR20##
Claim 13
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR21##
Claim 14
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR22##
Claim 15
Dependent Claim 16 words
A spiro-(fluoren-9,4'-imidazolidine)-2',5'-dione or pharmaceutically acceptable salt thereof as recited in claim 1 having the formula ##STR23##

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-03-20 1987-09-19 1988-03-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-03-20 1991-09-19 1992-03-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-03-20 1995-09-19 1996-03-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag